Emerging Trends and Competitive Landscape in the Gemigliptin Market The Gemigliptin Market is witnessing significant growth and innovation driven by the rising prevalence of diabetes worldwide. Gemigliptin, a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, is gaining traction as an effective treatment option for type 2 diabetes mellitus.
The global gemigliptin market size was valued at US$ 1.79 Bn in 2024 and is expected to reach US$...
0 Shares
345 Views
0 Reviews